• Home
  • Nieuws
  • Programma
  • Exposanten
  • Mediapartners
  • Locatie
  • Contact
  • Historie
    • LabAutomation 2022
    • LabAutomation online 2021
    • LabAutomation online kennisweek 2020
    • LabAutomation 2019
      • Programma 2019
      • Exposanten 2019
    • LabAutomation 2018
      • Presentaties en programma 2018
      • Exposanten 2018
    • LabAutomation 2017
      • Presentaties en programma 2017
      • Exposanten 2017
    • LabAutomation 2016
      • Presentaties en programma 2016
      • Exposanten 2016
    • LabAutomation 2015
      • Presentaties en programma 2015
      • Exposanten 2015
    • LabAutomation 2014
      • Presentaties en programma 2014
      • Exposanten 2014
  • Account
    • Login
  • Login
  • Zoeken

LabAutomation

LabAutomation

Experience the Future of Lab Automation Today

29 maart, 2016 door BD

 

BD Kiestra™ microbiology lab automation solutions support testing that is more efficient, accurate, timely and cost-effective, improving result quality and providing a fast return on investment.

As part of our broader microbiology solution offering of instruments, consumables, informatics and services, BD Kiestra delivers high-quality, actionable results, enhanced lab productivity and reduced overall costs. As each lab is unique, we will work with you to tailor our modular, scalable and customizable solutions to meet your lab’s needs.

 

BD Kiestra™ TLA (Total Lab Automation)

The BD Kiestra TLA offers total microbiology lab automation that maximizes throughput and staff efficiency to reduce turnaround time and deliver high quality results. Modular and flexible with integrated workbenches, the TLA can be configured to meet the unique space and capacity requirements of your lab.

 

BD Kiestra™ WCA (Work Cell Automation)

The compact design of the BD Kiestra WCA makes it the optimal solution for labs of all sizes.

Employing proven technology with modules that streamline specimen processing, plate transportation, incubation and digital imaging – the WCA simplifies processes while minimizing the need for lab redesign.

http://labautomationsolutions.bd.com/

 

 

Categorie: exposant, lid Tagged: Automation, BD, labautomation

Gerelateerd:

  • Terugblik LabAutomation event 2019
  • Telkens u een pipet neemt, houdt u de data-integriteit in een hand.
  • ELISA Methods with Biomek Workstations
  • Biomek Genomic Workstations

BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people’s health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 30,000 associates in more than 50 countries throughout the world.  The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

 

BD focuses strategically on achieving growth in three worldwide business segments: BD Medical, BD Diagnostics and BD Biosciences.

 

  • BD Medical is among the world’s leading suppliers of medical devices and a leading innovator in injection- and infusion-based drug delivery since 1906, when the Company built the first-ever facility in the U.S. to manufacture needles and syringes.

 

  • BD Diagnostics is a leading provider of products for the safe collection and transport of diagnostics specimens, as well as instruments and reagent systems to accurately detect a broad range of infectious diseases, healthcare-associated infections and cancers.

 

  • BD Biosciences is a world leader in bringing innovative diagnostic and research tools to life scientists, clinical researchers, laboratory professionals and clinicians who are involved in basic research, drug discovery and development, biopharmaceutical production and disease management.

Email: kristel_devylder@europe.bd.com

Website: http://www.bd.com/europe/

Contact FHI

Brancheorganisatie Laboratorium Technologie
Telefoon: +31 (0)33 465 75 07
www.fhi.nl/laboratoriumtechnologie

Disclaimer

Privacy FHI

Cookies

Copyright © 2023 · Onderdeel van FHI ·